Trial Profile
Response to VALDOXAN® and restoration of life rhythms in unipolar depression: VALDOXAN® D-Rhythm study.Phase IV interventional clinical study, multicenter
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Apr 2022
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 01 Apr 2022 Status changed from recruiting to completed.
- 07 Jun 2011 New trial record